Association Between Tumor Necrosis Factor-α Antagonists andRisk of Cancer in PatientsWith InflammatoryBowelDisease

Abstract

RESULTS During 489 433 person-years of follow-up (median, 9.3 years [interquartile range, 4.2-14.0]), 81 of 4553 patients exposed to TNF-α antagonists (1.8%) (median follow-up, 3.7 years [interquartile range, 1.8-6.0]) and 3465 of 51 593 unexposed patients (6.7%) developed cancer, yielding a fully adjusted RR of 1.07 (95% CI, 0.85-1.36). There was no… (More)

Topics

5 Figures and Tables

Cite this paper

@inproceedings{Andersen2014AssociationBT, title={Association Between Tumor Necrosis Factor-α Antagonists andRisk of Cancer in PatientsWith InflammatoryBowelDisease}, author={Nynne Nyboe Andersen}, year={2014} }